spacer
home > pmps > autumn 2008 > flexible packaging protects against contamination
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Flexible Packaging Protects Against Contamination

This article gives an overview of the regulatory background on the prevention of contamination during the manufacturing and packing process of APIs, drugs or vaccines. Flexible packaging could be an ideal solution, providing suitable protection for this purpose at a relatively low cost.

Fulfilment of regulatory compliance according to European Pharmacopoeia (EP) or United States Pharmacopeia (USP) is often a primary concern, along with suitable documentation and traceability of all qualityrelated items. However, flexible packaging has to fulfil further requirements; the cleanliness of both high-purity bulk material and the production area have to be protected.

Pharmaceutical and medical products are increasingly closely linked to cleanliness. The gap between the requirements of hospital used materials and the needs of the pharmaceutical industry is growing continuously. The cleanliness required for pharmaceuticals, especially for sterile active...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Benjamin Kepp has worked for Bischof + Klein GmbH & Co KG since 2000. In his apprenticeship he had the chance to combine working for B+K with studying economics and commercial law. A further study has successfully been finished with a state-approved BA thereafter. Nowadays, he is engaged as part of the Product Management for CleanFlex® packaging materials.
spacer
Benjamin Kepp
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Mr Turhan Ozen Chief Cargo Officer at Turkish Airlines elected to the International Air Cargo Association (TIACA) Committee

Turhan Ozen, serving as Chief Cargo Officer at the global brand Turkish Airlines, was elected to the International Air Cargo Association (TIACA) Committee, the joint voice of the industry that aims to enhance the air cargo profile with intensive efforts towards the global standards.
More info >>

White Papers

Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models

DrugDev

For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In today’s tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality. One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CRO’s, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement